An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety.

IF 5.6 Q1 ONCOLOGY
Sharath K Bhagavatula, Ryan Reichert, Sebastian W Ahn, Grace Foley, Zuzana Tatarova, Juraj Jakubik, Christine A Dominas, Courtney Marlin, Natalie Azzolini, Ellen Maloney, Samantha Martin, Destiny Matthew, Guigen Liu, Sajanlal Panikkanvalappil, Ezra Burch, Yan Epelboym, Nobuhiko Hata, Stuart G Silverman, Oliver Jonas
{"title":"An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety.","authors":"Sharath K Bhagavatula, Ryan Reichert, Sebastian W Ahn, Grace Foley, Zuzana Tatarova, Juraj Jakubik, Christine A Dominas, Courtney Marlin, Natalie Azzolini, Ellen Maloney, Samantha Martin, Destiny Matthew, Guigen Liu, Sajanlal Panikkanvalappil, Ezra Burch, Yan Epelboym, Nobuhiko Hata, Stuart G Silverman, Oliver Jonas","doi":"10.1148/rycan.250055","DOIUrl":null,"url":null,"abstract":"<p><p>Purpose To evaluate the technical feasibility and safety of a nonsurgical interventional method for placement and retrieval of implantable microdevices (IMDs) in a rabbit tumor model. Materials and Methods This prospective preclinical feasibility and safety study was conducted from March 2022 to October 2024. Interventional IMD placement and retrieval were performed in 12 rabbits with single hindlimb VX2 tumors. Four or five IMDs were placed per animal. Each IMD delivered microdose quantities of three drugs (doxorubicin, topotecan, sunitinib) into 18 spatially distinct microscopic tumor regions over 24-48 hours. An over-the-wire biopsy procedure was used to extract the IMDs and surrounding tumor. Technical success was defined per animal as retrieval of at least one tumor region containing each of the three drugs. Overall region-level retrieval success rate was calculated as the overall percentage of drug-exposed regions retrieved successfully. Safety was determined by monitoring animals for adverse events. Procedure durations were assessed to inform clinical translation. Statistical analysis included calculation of binomial 95% CIs for success rates and summary statistics (mean ± SD) for region yield and procedure times. Results Twelve rabbits received 52 IMDs (mean, 4.3 ± 0.5 per animal) generating 936 drug-exposure sites. Technical success was 100% (12 of 12; 95% CI: 73.5, 100). Mean per animal retrieval was 50.7 regions ± 11.4 (range, 33-69), with an overall region-level success rate of 65% (608 of 936; 95% CI: 62, 68). No Common Terminology Criteria for Adverse Events grade 2 (moderate) or higher adverse events were observed. In two animals, IMDs dislodged from the guidewire and were retained in the tumor; no symptoms developed, and no additional intervention was required (grade 1). Implantation procedure duration was 30.3 minutes ± 5.3 and retrieval procedure duration was 49.1 minutes ± 6.3. Conclusion Interventional IMD placement and retrieval in a rabbit soft tissue tumor model was technically feasible and safe. This approach demonstrated the capacity to recover multiple drug-exposed regions for in situ assessment of local drug effects. <b>Keywords:</b> Implantable Microdevice, Personalized Treatment, Percutaneous Biopsy, Phase 0 Trials, Microdosing, Interventional Radiology <i>Supplemental material is available for this article.</i> © RSNA, 2025.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 5","pages":"e250055"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12492436/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology. Imaging cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1148/rycan.250055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose To evaluate the technical feasibility and safety of a nonsurgical interventional method for placement and retrieval of implantable microdevices (IMDs) in a rabbit tumor model. Materials and Methods This prospective preclinical feasibility and safety study was conducted from March 2022 to October 2024. Interventional IMD placement and retrieval were performed in 12 rabbits with single hindlimb VX2 tumors. Four or five IMDs were placed per animal. Each IMD delivered microdose quantities of three drugs (doxorubicin, topotecan, sunitinib) into 18 spatially distinct microscopic tumor regions over 24-48 hours. An over-the-wire biopsy procedure was used to extract the IMDs and surrounding tumor. Technical success was defined per animal as retrieval of at least one tumor region containing each of the three drugs. Overall region-level retrieval success rate was calculated as the overall percentage of drug-exposed regions retrieved successfully. Safety was determined by monitoring animals for adverse events. Procedure durations were assessed to inform clinical translation. Statistical analysis included calculation of binomial 95% CIs for success rates and summary statistics (mean ± SD) for region yield and procedure times. Results Twelve rabbits received 52 IMDs (mean, 4.3 ± 0.5 per animal) generating 936 drug-exposure sites. Technical success was 100% (12 of 12; 95% CI: 73.5, 100). Mean per animal retrieval was 50.7 regions ± 11.4 (range, 33-69), with an overall region-level success rate of 65% (608 of 936; 95% CI: 62, 68). No Common Terminology Criteria for Adverse Events grade 2 (moderate) or higher adverse events were observed. In two animals, IMDs dislodged from the guidewire and were retained in the tumor; no symptoms developed, and no additional intervention was required (grade 1). Implantation procedure duration was 30.3 minutes ± 5.3 and retrieval procedure duration was 49.1 minutes ± 6.3. Conclusion Interventional IMD placement and retrieval in a rabbit soft tissue tumor model was technically feasible and safe. This approach demonstrated the capacity to recover multiple drug-exposed regions for in situ assessment of local drug effects. Keywords: Implantable Microdevice, Personalized Treatment, Percutaneous Biopsy, Phase 0 Trials, Microdosing, Interventional Radiology Supplemental material is available for this article. © RSNA, 2025.

癌症药物反应原位评估的介入放射学方法:临床前发展、可行性和安全性。
目的探讨一种非手术介入方法在兔肿瘤模型中植入和取出可植入微型装置(IMDs)的技术可行性和安全性。材料与方法该前瞻性临床前可行性和安全性研究于2022年3月至2024年10月进行。对12只兔后肢VX2单侧肿瘤行IMD置入术。每只动物放置4到5个imd。每个IMD在24-48小时内将三种药物(阿霉素、拓扑替康、舒尼替尼)的微剂量量递送到18个空间上不同的显微肿瘤区域。采用在线活检方法提取imd和周围肿瘤。技术上的成功被定义为每只动物至少有一个肿瘤区域包含这三种药物中的每一种。总体区域级检索成功率计算为药物暴露区域检索成功的总体百分比。通过监测动物的不良事件来确定安全性。评估手术持续时间,为临床翻译提供信息。统计分析包括计算成功率的二项95% ci和区域产率和手术时间的汇总统计(平均值±SD)。结果12只家兔共接受52次imd(平均每只4.3±0.5次),产生936个药物暴露位点。技术成功率为100% (12 / 12;95% CI: 73.5, 100)。平均每只动物检索为50.7±11.4个区域(范围,33-69),总体区域级成功率为65% (936 / 608;95% CI: 62, 68)。没有观察到不良事件的通用术语标准2级(中度)或更高的不良事件。在两只动物中,imd从导丝上脱落并保留在肿瘤中;没有出现症状,也不需要额外的干预(1级)。植入时间30.3分钟±5.3分钟,取出时间49.1分钟±6.3分钟。结论在兔软组织肿瘤模型中置入和取出IMD在技术上是可行和安全的。这种方法证明了恢复多个药物暴露区域的能力,以便对局部药物效应进行原位评估。关键词:植入式微设备,个性化治疗,经皮活检,0期试验,微剂量,介入放射学©rsna, 2025。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.00
自引率
2.30%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信